论文部分内容阅读
目的探讨莫西沙星用于下呼吸道感染的治疗效果。方法选取2014年5月至2015年5月期间在我院进行诊治的104例下呼吸道感染患者,通过计算机进行随机性分组,对照组52例患者采用左氧氟沙星进行治疗;研究组52例患者采用莫西沙星进行治疗。比较两组患者疗效。结果研究组患者的总有效率92.3%(48/52)远远高于对照组的76.9%(40/52),差异有统计学意义(P<0.05)。结论莫西沙星用于下呼吸道感染的疗效更加确切,安全性更高,可作为临床治疗的最佳抗菌药物。
Objective To investigate the therapeutic effect of moxifloxacin for lower respiratory tract infection. Methods A total of 104 patients with lower respiratory tract infection who were diagnosed and treated in our hospital from May 2014 to May 2015 were randomized by computer and 52 patients in the control group were treated with levofloxacin. Fifty-two patients in the study group were treated with moxisaban Star for treatment. Compare the efficacy of two groups of patients. Results The total effective rate of the study group was 92.3% (48/52), which was significantly higher than that of the control group (76.9%, 40/52). The difference was statistically significant (P <0.05). Conclusion Moxifloxacin is more effective and effective in the treatment of lower respiratory tract infections and can be used as the best antimicrobial agent for clinical treatment.